195 Episoder

  1. The Long-Term Safety of Momelotinib for Myelofibrosis: A Poster from ASH

    Publisert: 29.10.2024
  2. Poster Pearl: Elacestrant + Abemaciclib for ER+/HER2- Metastatic Breast Cancer

    Publisert: 29.10.2024
  3. Enhancing Outcomes in Relapsed/Refractory B-ALL with CAR T-Cell Therapy

    Publisert: 16.10.2024
  4. Momelotinib vs. Ruxolitinib: Comparing Efficacy in Myelofibrosis and Anemia Patients

    Publisert: 2.10.2024
  5. From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases

    Publisert: 16.9.2024
  6. Insights from ICARUS-Lung01: Efficacy and Safety of Dato-DXd for NSCLC

    Publisert: 9.9.2024
  7. Myeloma Matters: Bispecific Antibody Horizons: Dosing Strategies and Meeting Updates in Myeloma Care

    Publisert: 15.8.2024
  8. The Promise of MCED Testing: Easing the Burden of Cancer Screening Anxiety

    Publisert: 6.8.2024
  9. Uncovering New Biomarkers for RCC: A Review of Emerging Techniques

    Publisert: 30.7.2024
  10. The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes

    Publisert: 29.7.2024
  11. Delivering Guideline-Based Hepatocellular Carcinoma Care with an Interactive Tool

    Publisert: 23.7.2024
  12. Myeloma Matters: Prevention and Management of Bispecific Antibody–Associated Adverse Events in Multiple Myeloma

    Publisert: 18.7.2024
  13. Emerging Frontiers: CAR T-Cell Therapy for Solid Tumors in Thyroid Cancer

    Publisert: 16.7.2024
  14. Optimizing Biomarker Testing to Guide Treatment Selection for Metastatic Colorectal Cancer

    Publisert: 16.7.2024
  15. MCED Testing: Confirming a Positive Result with Diagnostic Follow-Up

    Publisert: 11.7.2024
  16. Current Updates in Brain Imaging and Neurodegenerative Diseases

    Publisert: 9.7.2024
  17. Dual Challenges: Managing Hepatocellular Carcinoma with Hepatitis B Co-Infection

    Publisert: 9.7.2024
  18. Uncovering Barriers to HCC Surveillance in Patients with Cirrhosis

    Publisert: 3.7.2024
  19. Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings

    Publisert: 2.7.2024
  20. Salivary Toxicity from PSMA-Targeted Radiopharmaceuticals in mCRPC

    Publisert: 1.7.2024

3 / 10

Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer. Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.

Visit the podcast's native language site